Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.

Marjanovic, Irena; Karan-Djurasevic, Teodora; Ugrin, Milena; Virijevic, Marijana; Vidovic, Ana; Tomin, Dragica; Suvajdzic Vukovic, Nada; Pavlovic, Sonja; Tosic, Natasa

Marjanovic, Irena; Karan-Djurasevic, Teodora; Ugrin, Milena; Virijevic, Marijana; Vidovic, Ana; Tomin, Dragica; Suvajdzic Vukovic, Nada; Pavlovic, Sonja; Tosic, Natasa.

Afiliación

Marjanovic I; Laboratory for Molecular Biomedicine, Institute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Karan-Djurasevic T; Laboratory for Molecular Biomedicine, Institute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Ugrin M; Laboratory for Molecular Biomedicine, Institute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Virijevic M; Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia.
Vidovic A; Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia.
Tomin D; Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia.
Suvajdzic Vukovic N; Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia.
Pavlovic S; Laboratory for Molecular Biomedicine, Institute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Tosic N; Laboratory for Molecular Biomedicine, Institute for Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia. Electronic address: natasa.tosic@imgge.bg.ac.rs.

Clin Lymphoma Myeloma Leuk ; 17(5): 312-319, 2017 05.

Article en En | MEDLINE | ID: mdl-28163010

Asunto(s)

Biomarcadores de Tumor/genética; Leucemia Mieloide Aguda/patología; Neoplasia Residual/patología; Proteínas WT1/genética; Adulto; Anciano; Supervivencia sin Enfermedad; Femenino; Perfilación de la Expresión Génica; Genes del Tumor de Wilms; Humanos; Cariotipo; Leucemia Mieloide Aguda/genética; Leucemia Mieloide Aguda/mortalidad; Masculino; Persona de Mediana Edad; Neoplasia Residual/genética; Neoplasia Residual/mortalidad; Nucleofosmina; Pronóstico; Transcriptoma; Adulto Joven

Palabras clave

AML with normal karyotype; Minimal residual disease; Prognosis; Real-time PCR; WT1 expression

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Biomarcadores de Tumor / Neoplasia Residual / Proteínas WT1 Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google